Leuplin

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

LeuprolideLeuprolide Acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Dose-finding study of Leuplin depot for prevention of premature luteinizing hormone surge during controlled ovarian stimulation: a pilot study in intrauterine insemination treatment.
OBJECTIVE The standard dose of depot gonadotropin releasing hormone agonist (GnRHa) may be too much to prevent premature… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2007
2007
GnRH agonist acts as ovarian protection in chemotherapy induced gonadotoxicity: an experiment using a rat model.
To reduce chemotherapy induced gonadotoxicity, co-treatment with gonadotropin releasing hormone against analogue (GnRHa) was… (More)
  • table 1
  • figure 3
  • figure 1
  • figure 2
Is this relevant?
2006
2006
Ultrasonographic evaluation of the change in uterine fibroids induced by treatment with a GnRH analog.
OBJECTIVE To investigate the change in volume of uterine fibroids after GnRH analog (GnRHa) treatment. MATERIALS AND METHODS… (More)
Is this relevant?
2006
2006
Skin Reactions to 3-month Depot Type of Luteinizing Hormone-Releasing Hormone Agonist Therapy
Objective Recently, skin reactions to luteinizing hormone-releasing hormone (LH-RH) agonist therapy were reported after the 3… (More)
  • table 1
  • table 3
Is this relevant?
2004
2004
Prevention by 17beta-estradiol and progesterone of calcitonin gene-related peptide-induced elevation of skin temperature in castrated male rats.
OBJECTIVES To clarify the relationship between calcitonin gene-related peptide (CGRP) and ovarian hormones (17beta-estradiol and… (More)
Is this relevant?
2003
2003
Involvement of calcitonin gene-related peptide in elevation of skin temperature in castrated male rats.
OBJECTIVES To assess the involvement of calcitonin gene-related peptide (CGRP) in the occurrence of hot flashes in men after… (More)
Is this relevant?
2003
2003
Enhanced polyadenosine diphosphate-ribosylation in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
This study aimed to examine the activation of poly(ADP-ribose) polymerase (PARP) and the accumulation of its end product, poly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Fas and its ligand, caspases, and bcl-2 expression in gonadotropin-releasing hormone agonist-treated uterine leiomyoma.
GnRH agonist (GnRH-a) therapy is known to shrink uterine leiomyoma, although the molecular mechanisms responsible for this effect… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2002
2002
[Clinical effects of a 3-month formulation LH-RH agonist, TAP-144-SR (3M) in prostate cancer patients].
A randomized, multicenter, double-blind, parallel-group study was conducted in order to evaluate the hormonal kinetics… (More)
Is this relevant?
2001
2001
[Clinical efficacy of leuprolide acetate and combined treatment with estramustine for advanced prostate cancer].
BACKGROUND/PURPOSE Twenty-two institutes have organized Keio University Prostate Cancer Study Group to study clinical efficacy… (More)
Is this relevant?